RVMD - Why did Revolution Medicines go up? Encouraging data for two drugs
2023-10-16 15:55:39 ET
More on Revolution Medicines
- Revolution Medicines: A Big Pipeline In Need Of Big Data
- Revolution Medicines' Strategic Edge In RAS-Driven Oncology
- Revolution Medicines, Inc. (RVMD) Q2 2023 Earnings Call Transcript
- Revolution Medicines stock rallies 21% amid data presentations
- Revolution Medicines will buy EQRx in an all-stock transaction
For further details see:
Why did Revolution Medicines go up? Encouraging data for two drugs